The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease : a critical analysis of α-synuclein stagingKALAITZAKIS, M. E; GRAEBER, M. B; GENTLEMAN, S. M et al.Neuropathology and applied neurobiology (Print). 2008, Vol 34, Num 3, pp 284-295, issn 0305-1846, 12 p.Article

Modafinil prevents the MPTP-induced increase in GABA_A receptor binding in the internal globus pallidus of MPTP-treated common marmosetsZENG, B.-Y; SMITH, L. A; PEARCE, R. K. B et al.Neuroscience letters. 2004, Vol 354, Num 1, pp 6-9, issn 0304-3940, 4 p.Article

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological studyLITVAN, I; CAMPBELL, G; MANGONE, C. A et al.Brain. 1997, Vol 120, pp 65-74, issn 0006-8950, 1Article

Evidence against a reliable staging system of α-synuclein pathology in Parkinson's diseaseKALAITZAKIS, M. E; GRAEBER, M. B; GENTLEMAN, S. M et al.Neuropathology and applied neurobiology (Print). 2009, Vol 35, Num 1, pp 125-126, issn 0305-1846, 2 p.Article

Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeysLYRAS, L; ZENG, B-Y; MCKENZIE, G et al.Journal of neural transmission. 2002, Vol 109, Num 1, pp 53-67, issn 0300-9564Article

L-Dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observationsPEARCE, R. K. B; HEIKKILÄ, M; LINDEN, I.-B et al.Psychopharmacologia. 2001, Vol 156, Num 4, pp 402-409, issn 0033-3158Article

Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmosetJENNER, P; ZENG, B.-Y; SMITH, L. A et al.Experimental brain research. 2000, Vol 133, Num 2, pp 178-188, issn 0014-4819Article

Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)LITVAN, I; AGID, Y; MCKEE, A et al.Neurology. 1996, Vol 46, Num 4, pp 922-930, issn 0028-3878Article

Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's diseaseDUKE, D. C; MORAN, L. B; KALAITZAKIS, M. E et al.Neurogenetics (Oxford. Print). 2006, Vol 7, Num 3, pp 139-148, issn 1364-6745, 10 p.Article

What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic studyLITVAN, I; AGID, Y; MCKEE, A et al.Neurology. 1997, Vol 49, Num 1, pp 62-69, issn 0028-3878Article

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's diseasePEARCE, R. K. B; OWEN, A; DANIEL, S et al.Journal of neural transmission. 1997, Vol 104, Num 6-7, pp 661-677, issn 0300-9564Article

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix jacchus)PEARCE, R. K. B; JACKSON, M; SMITH, L et al.Movement disorders. 1995, Vol 10, Num 6, pp 731-740, issn 0885-3185Article

Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaPEARCE, R. K. B; SEEMAN, P; JELLINGER, K et al.European neurology. 1990, Vol 30, pp 9-14, issn 0014-3022, SUP1Conference Paper

Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosetsTEL, B. C; ZENG, B.-Y; CANNIZZARO, C et al.Neuroscience. 2002, Vol 115, Num 4, pp 1047-1058, issn 0306-4522, 12 p.Article

Actions of the D₁ agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsPEARCE, R. K. B; JACKSON, M; BRITTON, D. R et al.Psychopharmacologia. 1999, Vol 142, Num 1, pp 51-60, issn 0033-3158Article

Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degenerationLITVAN, I; GRIMES, D. A; LANG, A. E et al.Journal of neurology. Supplement. 1999, Vol 246, Num 2, pp II1-II5, issn 0939-1517Conference Paper

What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic studyLITVAN, I; GOETZ, C. G; VERNY, M et al.Archives of neurology (Chicago). 1997, Vol 54, Num 8, pp 937-944, issn 0003-9942Article

The anterior olfactory nucleus in Parkinson's diseasePEARCE, R. K. B; HAWKES, C. H; DANIEL, S. E et al.Movement disorders. 1995, Vol 10, Num 3, pp 283-287, issn 0885-3185Conference Paper

The medial and lateral substantia nigra in Parkinson's disease : mRNAa profiles associated with higher brain tissue vulnerabilityDUKE, D. C; MORAN, L. B; PEARCE, R. K. B et al.Neurogenetics (Oxford. Print). 2007, Vol 8, Num 2, pp 83-94, issn 1364-6745, 12 p.Article

Chronic high dose L-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys : an autoradiographic studyZENG, B.-Y; PEARCE, R. K. B; MACKENZIE, G. M et al.Journal of neural transmission. 2001, Vol 108, Num 8-9, pp 925-941, issn 0300-9564Article

Combined use of the adenosine A_2A antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeysKANDA, T; JACKSON, M. J; SMITH, L. A et al.Experimental neurology (Print). 2000, Vol 162, Num 2, pp 321-327, issn 0014-4886Article

De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmosetPEARCE, R. K. B; BANERJI, T; JENNER, P et al.Movement disorders. 1998, Vol 13, Num 2, pp 234-241, issn 0885-3185Article

Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examinationWENNING, G. K; LITVAN, I; PEARCE, R. K. B et al.Journal of neurology, neurosurgery and psychiatry. 1998, Vol 64, Num 2, pp 184-189, issn 0022-3050Article

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival : a clinicopathological studyLITVAN, I; MANGONE, C. A; MCKEE, A et al.Journal of neurology, neurosurgery and psychiatry. 1996, Vol 60, Num 6, pp 615-620, issn 0022-3050Article

Page / 2